CREO.L AI Price Prediction

Track CREO.L's AI-powered predictions, market trends, and investment insights.

CREO.L Sentiment CREO.L StockTwits CREO.L Reddit

Mock Tradesimulated, no real money

You don't hold CREO.L in your mock portfolio yet.

CREO.L AI Price Prediction

Track CREO.L's AI-powered predictions, market trends, and investment insights.

CREO.L Sentiment CREO.L StockTwits CREO.L Reddit

Evidence Stack

What Changed?

Key moves vs recent baseline (last day / last week)

Price (1d)-2.6%

Price (7d)-5.2%

Volume vs avg0.5x

Volatility vs normal0.4x

Why Now?

Plain-English summary of the biggest drivers (informational)

Risk Flags

Potential risk factors to review

No flags triggered by these checks.

Based on earnings timing, volatility, liquidity and crowd activity. Informational signals only — not investment advice.

Invalidation Signals

Reassess your thesis if any of these occur:

Price breaks below ~$11.38 (recent support level)

Upgrade to see the full Evidence Stack

What Changed, Why Now, and Risk Flags — available on the Investor plan and above

Get Started

CREO.L AI Stock Analysis

Financial Performance

bearish

The company is currently loss-making, as indicated by its negative EPS and negative P/E ratio. This suggests that, despite any potential growth story, Creo Medical has not yet demonstrated sustainable profitability, which is a key risk factor for equity holders.

Negative EPS of -0.04 indicates the company is not generating positive earnings for shareholders.
A negative P/E ratio of -3.62 confirms that the market is valuing a loss-making business on expectations of future improvement rather than current profits.
Absent evidence of strong margin expansion or a clear path to profitability, the current financial profile leans toward higher risk and justifies a cautious stance.

Stock Price & Technicals

neutral

The stock has shown short-term strength, rising 11.5% over the last month and trading above its 200-day moving average. However, the RSI above 70 signals overbought conditions, suggesting elevated risk of a pullback after the recent run-up.

Current price of $14.50 is materially above the 200-day moving average of $12.26, indicating a positive intermediate-term trend.
RSI at 74.59 is in overbought territory, often associated with stretched short-term momentum and potential for mean reversion.
An 11.5% gain in the last month reflects strong recent buying interest, but with no supporting profitability, the move may be driven more by sentiment and speculation than fundamentals.

Alternative Data Signals

neutral

Alternative data show a modest and relatively static digital footprint with limited recent growth in engagement. Social media and web traffic levels are small for a listed company, but the stable LinkedIn base suggests some professional awareness and industry presence.

Estimated web traffic of 6,501 visitors per month is low and there is no indication of strong growth momentum, limiting evidence of accelerating commercial interest.
Social media followings are modest (e.g., 894 on Twitter/X, 419 on Facebook, 177 on YouTube) with negligible growth over the last 90 days, implying flat brand and retail-investor engagement.
LinkedIn following of 11,309 suggests reasonable professional and industry visibility, but 0 current job openings and no growth in postings point to a lack of expansion signals from hiring data.

Conclusion

bearish

Overall, the setup appears bearish from a fundamental perspective, with the company still unprofitable and alternative data not signaling strong commercial acceleration. While technicals show recent strength, the overbought RSI and price extended above the 200-day moving average raise the risk of a near-term correction, especially given weak earnings support.

Loss-making fundamentals and negative earnings metrics weigh heavily on the investment case, making the stock dependent on future execution rather than current performance.
Recent price strength and positive trend are offset by overbought technicals and tepid alternative data, leading to a cautious, fundamentally bearish overall view despite short-term momentum.

AI Score

Hold

Alternative4

Fundamental1

Technical7

Our AI Score rates companies on a scale from 0 to 10, based on alternative data points such as web traffic, app downloads, and job postings — combined with financial health indicators and technical signals.

Mock Tradesimulated, no real money

You don't hold CREO.L in your mock portfolio yet.